UK projects growth in drug spending through 2014

04/15/2013 | PharmaTimes (U.K.)

Annual spending in the U.K. will increase by 0.5% to 1.8% on branded drugs and 10% to 11% on generics through 2015, according to the Office of Health Economics. Analysts used a new "bottom-up" method to base the forecast on input from industry executives regarding new branded products as well as generic and biosimilar drugs.

View Full Article in:

PharmaTimes (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN